North Atlantic marine biogenic silica accumulation through the early-to-mid Paleogene: implications for ocean circulation and silicate weathering feedback

The Paleogene history of biogenic opal accumulation in the North Atlantic provides insight into both the evolution of deep-water circulation in the Atlantic basin, and weathering responses to major climate shifts. However, existing records are compromised by low temporal resolution and/or stratigraphic discontinuities. In order to address this problem, we present a multi-site, high-resolution record of biogenic silica (bioSiO2) accumulation from Blake Nose (ODP Leg 171B, western North Atlantic) spanning the early Paleocene through late Eocene time interval (~65‒34 Ma). This record represents the longest single-locality history of marine bioSiO2 burial compiled to date and offers a unique perspective into changes in bioSiO2 fluxes through the early-to-mid Paleogene extreme greenhouse interval and subsequent period of long-term cooling. Blake Nose bioSiO2 fluxes display prominent fluctuations that we attribute to variations in sub-thermocline nutrient supply via cyclonic eddies associated with the Gulf Stream. Whereas few constraints are available on the bioSiO2 flux pulses peaking in the early Paleocene and early Eocene, a middle Eocene interval of elevated bioSiO2 flux between ~46 and 42 Ma is proposed to reflect nutrient enrichment due to invigorated overturning circulation following an early onset of Northern Component Water export from the Norwegian-Greenland Sea at ~49 Ma. Comparison of our North Atlantic record against published Pacific bioSiO2 flux records indicates a diminished nutrient supply to the Atlantic between ~42 and 38 Ma, interpreted as a response to weakening of the overturning circulation. Subsequently, a deep-water circulation regime favoring limited bioSiO2 burial in Atlantic and enhanced bioSiO2 burial in the Pacific was established after ~38 Ma, likely in association with a further invigoration of deep-water export from the North Atlantic. We also observe that Blake Nose bioSiO2 fluxes through the middle Eocene cooling interval (~48 to 34 Ma) are consistently higher than background fluxes throughout the late Paleocene‒early Eocene interval of intense greenhouse warmth. This observation is consistent with a temporally variable rather than constant silicate weathering feedback strength model for the Paleogene, which would instead predict that marine bioSiO2 burial should peak during periods of extreme warming

ADPedKD: A Global Online Platform on the Management of Children With ADPKD

Background: Autosomal dominant polycystic kidney disease (ADPKD) is the most common monogenic cause of renal failure. For several decades, ADPKD was regarded as an adult-onset disease. In the past decade, it has become more widely appreciated that the disease course begins in childhood. However, evidence-based guidelines on how to manage and approach children diagnosed with or at risk of ADPKD are lacking. Also, scoring systems to stratify patients into risk categories have been established only for adults. Overall, there are insufficient data on the clinical course during childhood. We therefore initiated the global ADPedKD project to establish a large international pediatric ADPKD cohort for deep characterization. Methods: Global ADPedKD is an international multicenter observational study focusing on childhood-diagnosed ADPKD. This collaborative project is based on interoperable Web-based databases, comprising 7 regional and independent but uniformly organized chapters, namely Africa, Asia, Australia, Europe, North America, South America, and the United Kingdom. In the database, a detailed basic data questionnaire, including genetics, is used in combination with data entry from follow-up visits, to provide both retrospective and prospective longitudinal data on clinical, radiologic, and laboratory findings, as well as therapeutic interventions. Discussion: The global ADPedKD initiative aims to characterize in detail the most extensive international pediatric ADPKD cohort reported to date, providing evidence for the development of unified diagnostic, follow-up, and treatment recommendations regarding modifiable disease factors. Moreover, this registry will serve as a platform for the development of clinical and/or biochemical markers predicting the risk of early and progressive disease